You are here
NEMUCORE MEDICAL INNOVATIONS, INC.
UEI: XJFVQ8JVRED5
# of Employees: 8
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Modified MIS Production & Process Development for Preclinical & Clinical Studies
Amount: $225,000.00DESCRIPTION provided by applicant Ovarian cancer is a highly lethal gynecologic cancer with an estimated new cases and approximately deaths in the USA per year In a large majority of ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Expression System and Process Development for MIS Scale Up
Amount: $224,915.00DESCRIPTION (provided by applicant): Ovarian cancer is a highly lethal gynecologic cancer with an estimated 21,860 new cases and approximately 13,850 deaths in the USA per year. A large majority of ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Targeted Docetaxel-Nanocolloid for the Treatment of Ovarian Cancer
Amount: $288,302.00DESCRIPTION (provided by applicant): PROJECT SUMMARY This proposal is a Phase 1 proposal in response to The National Institute of Health Small Business Innovation Research (SBIR) Program call for prop ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
EGFR-Targeted Nanoemulsions for Imaging and Therapy of Ovarian Cancer
Amount: $302,461.00DESCRIPTION (provided by applicant): Today 70% of patients with advanced ovarian cancer will achieve clinically complete remission with front line treatments of carboplatin and paclitaxel, unfortunate ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health
